Your browser doesn't support javascript.
loading
Shared Genetics of Multiple System Atrophy and Inflammatory Bowel Disease.
Shadrin, Alexey A; Mucha, Sören; Ellinghaus, David; Makarious, Mary B; Blauwendraat, Cornelis; Sreelatha, Ashwin A K; Heras-Garvin, Antonio; Ding, Jinhui; Hammer, Monia; Foubert-Samier, Alexandra; Meissner, Wassilios G; Rascol, Olivier; Pavy-Le Traon, Anne; Frei, Oleksandr; O'Connell, Kevin S; Bahrami, Shahram; Schreiber, Stefan; Lieb, Wolfgang; Müller-Nurasyid, Martina; Schminke, Ulf; Homuth, Georg; Schmidt, Carsten O; Nöthen, Markus M; Hoffmann, Per; Gieger, Christian; Wenning, Gregor; Gibbs, J Raphael; Franke, Andre; Hardy, John; Stefanova, Nadia; Gasser, Thomas; Singleton, Andrew; Houlden, Henry; Scholz, Sonja W; Andreassen, Ole A; Sharma, Manu.
Afiliación
  • Shadrin AA; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Mucha S; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Ellinghaus D; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Makarious MB; Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and, Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Blauwendraat C; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
  • Sreelatha AAK; Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany.
  • Heras-Garvin A; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Ding J; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
  • Hammer M; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
  • Foubert-Samier A; Service de Neurologie, CRMR Atrophie Multisystématisée, CHU Bordeaux, Bordeaux, France.
  • Meissner WG; Inserm, UMR1219, Bordeaux Population Health Research Center, Bordeaux University, ISPED, Bordeaux, France.
  • Rascol O; Service de Neurologie, CRMR Atrophie Multisystématisée, CHU Bordeaux, Bordeaux, France.
  • Pavy-Le Traon A; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, CNRS, Bordeaux, France.
  • Frei O; Centre de Reference Maladie Rare Atrophie MultiSystématisée, Centre d'Investigation, Clinique CIC 1436, Services de Pharmacologie Clinique et Neurosciences, NeuroToul COEN Center, Toulouse, France.
  • O'Connell KS; Centre Hospitalo-Universitaire de Toulouse, 3, INSERM, Toulouse, France.
  • Bahrami S; Neurology Department, French Reference Centre for MSA, University Hospital of Toulouse and INSERM U 1048, Institute of Cardiovascular and Metabolic Diseases, Toulouse, France.
  • Schreiber S; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Lieb W; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Müller-Nurasyid M; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Schminke U; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Homuth G; First Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Schmidt CO; Institute of Epidemiology and Biobank PopGen, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Nöthen MM; Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
  • Hoffmann P; Chair of Genetic Epidemiology, IBE, Faculty of Medicine, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.
  • Gieger C; Department of Internal Medicine I (Cardiology), Hospital of the Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.
  • Wenning G; Department of Neurology, University Medicine Greifswald, Greifswald, Germany.
  • Gibbs JR; Institute for Community Medicine, Study of Health in Pomerania/KEF, University Medicine Greifswald, Greifswald, Germany.
  • Franke A; Institute of Human Genetics, University of Bonn, Bonn, Germany.
  • Hardy J; Institute of Human Genetics, University of Bonn, Bonn, Germany.
  • Stefanova N; Research Unit of Molecular Epidemiology, Institute of Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
  • Gasser T; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Houlden H; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
  • Scholz SW; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • Andreassen OA; Rita Lila Weston Institute, University College London, London, UK.
  • Sharma M; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Mov Disord ; 36(2): 449-459, 2021 02.
Article en En | MEDLINE | ID: mdl-33107653
ABSTRACT

BACKGROUND:

Multiple system atrophy (MSA) is a rare neurodegenerative disease characterized by intracellular accumulations of α-synuclein and nerve cell loss in striatonigral and olivopontocerebellar structures. Epidemiological and clinical studies have reported potential involvement of autoimmune mechanisms in MSA pathogenesis. However, genetic etiology of this interaction remains unknown. We aimed to investigate genetic overlap between MSA and 7 autoimmune diseases and to identify shared genetic loci.

METHODS:

Genome-wide association study summary statistics of MSA and 7 autoimmune diseases were combined in cross-trait conjunctional false discovery rate analysis to explore overlapping genetic background. Expression of selected candidate genes was compared in transgenic MSA mice and wild-type mice. Genetic variability of candidate genes was further investigated using independent whole-exome genotyping data from large cohorts of MSA and autoimmune disease patients and healthy controls.

RESULTS:

We observed substantial polygenic overlap between MSA and inflammatory bowel disease and identified 3 shared genetic loci with leading variants upstream of the DENND1B and RSP04 genes, and in intron of the C7 gene. Further, the C7 gene showed significantly dysregulated expression in the degenerating midbrain of transgenic MSA mice compared with wild-type mice and had elevated burden of protein-coding variants in independent MSA and inflammatory bowel disease cohorts.

CONCLUSION:

Our study provides evidence of shared genetic etiology between MSA and inflammatory bowel disease with an important role of the C7 gene in both phenotypes, with the implication of immune and gut dysfunction in MSA pathophysiology. © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Atrofia de Múltiples Sistemas Límite: Animals / Humans Idioma: En Revista: Mov Disord Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Noruega

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Atrofia de Múltiples Sistemas Límite: Animals / Humans Idioma: En Revista: Mov Disord Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Noruega